Wipro secures $400-m contract from Takeda Pharmaceuticals

Wipro Ltd, India's third largest software exporter, has bagged a $400 million deal from Takeda Pharmaceutical, the largest pharmaceutical company in Japan.

Under the contract, Wipro will provide IT infrastructure management services covering Takeda globally, touching 30,000 users in 16 different languages, operating out of data centres in Asia, Europe and America.

Wipro did not disclose the size or the terms of this deal.

''Wipro is leveraging its experience in enabling global pharma companies to achieve a leaner and standardised IT workplace and implement newer business models,'' Sangita Singh, chief executive of healthcare and life science business unit at Wipro, said.

''This strategic partnership will build advanced value in Takeda's operations by consolidating IT platforms across the organisation'', the company said in a release.

Wipro will build and maintain an "as-a-service" global platform for Takeda that will drive synergies across its global entities through standardisation of IT architecture.

"Wipro will deliver the "as-a-service" on demand model, which is redefining the way organisations purchase technology. With our global delivery capabilities, Wipro will drive Takeda's IT infrastructure, consolidating and optimizing resources across the organization," added G K Prasanna, chief executive of global infrastructure services and product engineering services at Wipro Ltd.